Start your certification to prescribe FDA-approved Optune Lua

Begin today
Optune Lua—For unresectable, locally advanced or metastatic, MALIGNANT PLEURAL MESOTHELIOMA (MPM)1

ENTER AN EXCITING
ERA IN SURVIVAL

Consider Optune Lua for your next MPM patient

STELLAR Clinical Results: Patients who used Optune Lua first line together with pemetrexed + cisplatin or carboplatin achieved 18.2 months median OS with no added systemic AEs1,2

STELLAR: Primary endpoint: 18.2 months. Median OS (95% CI 12.1-25.8). In a population that includes patients with epithelioid and nonepithelioid histologies.

Optune Lua approval was based on the STELLAR study: a prospective, multicenter, single-arm, phase 2 study designed to study the safety and efficacy of Optune Lua and pemetrexed + cisplatin or carboplatin first line in patients with unresectable, locally advanced or metastatic, MPM.1,2

No systemic AEs were considered to be related to the use of Optune Lua

  • The only AE attributed to Optune Lua use was skin irritation (71% of patients); 66% mild-to-moderate and 5% severe. No SAEs were considered related to device use1,2
View STELLAR efficacy outcomes View STELLAR safety results
The second-generation Optune Lua system
Helpful resources for you and your patients

AEs, adverse events; SAEs, serious adverse events.

References: 1. Optune Lua. Instructions for Use for Unresectable Malignant Pleural Mesothelioma. Novocure; 2021. 2. Ceresoli GL, Aerts JG, Dziadziuszko R, et al. Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial. Lancet Oncol. 2019;20(12):1702-1709 doi:10.1016/S1470-2045(19)30532-7 3. Optune Lua. Patient Information and Operation Manual for Unresectable Malignant Pleural Mesothelioma. Novocure; 2021.

Next: FDA approval for unresectable MPM
Indications For Use
jump to isi

The Optune Lua System is indicated for the treatment of adult patients with unresect…

Leaving OptuneLua.com

Novocure® does not review the information contained on this website and/or database for content, accuracy, or completeness. Use of and access to this information is subject to the terms, limitations, and conditions set by the website and/or database producer.

Novocure makes no representation as to the accuracy or any other aspect of the information contained on such website and/or database, nor does Novocure necessarily endorse such website and/or database.